NorthCoast Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $565K | Sell |
3,113
-13,567
| -81% | -$2.46M | 0.02% | 332 |
|
|
2021
Q2 | $3.36M | Buy |
16,680
+1,795
| +12% | +$362K | 0.12% | 133 |
|
|
2021
Q1 | $3.2M | Buy |
14,885
+8,233
| +124% | +$1.77M | 0.13% | 129 |
|
|
2020
Q4 | $1.57M | Sell |
6,652
-14,447
| -68% | -$3.41M | 0.07% | 165 |
|
|
2020
Q3 | $5.74M | Buy |
21,099
+14,354
| +213% | +$3.91M | 0.29% | 74 |
|
|
2020
Q2 | $1.96M | Sell |
6,745
-1,342
| -17% | -$390K | 0.11% | 114 |
|
|
2020
Q1 | $1.92M | Buy |
+8,087
| New | +$1.92M | 0.12% | 105 |
|
|
2019
Q3 | – | Sell |
-6,327
| Closed | -$1.16M | – | 279 |
|
|
2019
Q2 | $1.16M | Buy |
6,327
+247
| +4% | +$45.3K | 0.07% | 143 |
|
|
2019
Q1 | $1.12M | Sell |
6,080
-806
| -12% | -$148K | 0.07% | 149 |
|
|
2018
Q4 | $1.14M | Buy |
6,886
+3,328
| +94% | +$551K | 0.09% | 133 |
|
|
2018
Q3 | $686K | Sell |
3,558
-76
| -2% | -$14.7K | 0.04% | 167 |
|
|
2018
Q2 | $618K | Buy |
3,634
+76
| +2% | +$12.9K | 0.06% | 143 |
|
|
2018
Q1 | $580K | Sell |
3,558
-912
| -20% | -$149K | 0.05% | 153 |
|
|
2017
Q4 | $670K | Hold |
4,470
| – | – | 0.06% | 149 |
|
|
2017
Q3 | $680K | Sell |
4,470
-1,599
| -26% | -$243K | 0.08% | 134 |
|
|
2017
Q2 | $782K | Buy |
+6,069
| New | +$782K | 0.09% | 139 |
|